Improving Adherence to Web-Based and Mobile Technologies for People with Psychosis:Systematic review of New Potential Predictors of Adherence by Killikelly, Clare et al.
Aberystwyth University
Improving Adherence to Web-Based and Mobile Technologies for People with
Psychosis
Killikelly, Clare; He, Zhimin; Reeder, Clare; Wykes, Til
Published in:
Journal of Medical Internet Research
DOI:
10.2196/mhealth.7088
Publication date:
2017
Citation for published version (APA):
Killikelly, C., He, Z., Reeder, C., & Wykes, T. (2017). Improving Adherence to Web-Based and Mobile
Technologies for People with Psychosis: Systematic review of New Potential Predictors of Adherence. Journal of
Medical Internet Research , 5(7), [e94]. https://doi.org/10.2196/mhealth.7088
Document License
CC BY
General rights
Copyright and moral rights for the publications made accessible in the Aberystwyth Research Portal (the Institutional Repository) are
retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the
legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the Aberystwyth Research Portal for the purpose of private study or
research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the Aberystwyth Research Portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
tel: +44 1970 62 2400
email: is@aber.ac.uk
Download date: 09. Jul. 2020
Original Paper
Improving Adherence to Web-Based and Mobile Technologies
for People With Psychosis: Systematic Review of New Potential
Predictors of Adherence
Clare Killikelly1,2, DClinPsy, PhD; Zhimin He1,3, PhD; Clare Reeder1, DClinPsy, PhD; Til Wykes1,4, Mphil, DPhil
1Institute of Psychiatry, Psychology & Neuroscience, Department of Psychology, King's College London, London, United Kingdom
2Division of Psychopathology and Clinical Intervention, Department of Psychology, University of Zurich, Zurich, Switzerland
3Department of Psychology, Aberystwyth University, Ceredigion, United Kingdom
4South London and Maudsley NHS Foundation Trust, London, United Kingdom
Corresponding Author:
Clare Killikelly, DClinPsy, PhD
Institute of Psychiatry, Psychology & Neuroscience
Department of Psychology
King's College London
PO 78, Institute of Psychiatry Psychology and Neuroscience, 4, Windsor Walk
London, SE5 8AF
United Kingdom
Phone: 44 044 635 7309
Fax: 44 044 635 7319
Email: clare.killikelly@kcl.ac.uk
Abstract
Background: Despite the boom in new technologically based interventions for people with psychosis, recent studies suggest
medium to low rates of adherence to these types of interventions. The benefits will be limited if only a minority of service users
adhere and engage; if specific predictors of adherence can be identified then technologies can be adapted to increase the service
user benefits.
Objective: The study aimed to present a systematic review of rates of adherence, dropout, and approaches to analyzing adherence
to newly developed mobile and Web-based interventions for people with psychosis. Specific predictors of adherence were also
explored.
Methods: Using keywords (Internet or online or Web-based or website or mobile) AND (bipolar disorder or manic depression
or manic depressive illness or manic-depressive psychosis or psychosis or schizophr* or psychotic), the following databases were
searched: OVID including MedLine, EMBASE and PsychInfo, Pubmed and Web of Science. The objectives and inclusion criteria
for suitable studies were defined following PICOS (population: people with psychosis; intervention: mobile or Internet-based
technology; comparison group: no comparison group specified; outcomes: measures of adherence; study design: randomized
controlled trials (RCT), feasibility studies, and observational studies) criteria. In addition to measurement and analysis of adherence,
two theoretically proposed predictors of adherence were examined: (1) level of support from a clinician or researcher throughout
the study, and (2) level of service user involvement in the app or intervention development. We provide a narrative synthesis of
the findings and followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines for
reporting systematic reviews.
Results: Of the 20 studies that reported a measure of adherence and a rate of dropout, 5 of these conducted statistical analyses
to determine predictors of dropout, 6 analyzed the effects of specific adherence predictors (eg, symptom severity or type of
technological interface) on the effects of the intervention, 4 administered poststudy feedback questionnaires to assess continued
use of the intervention, and 2 studies evaluated the effects of different types of interventions on adherence. Overall, the percentage
of participants adhering to interventions ranged from 28-100% with a mean of 83%. Adherence was greater in studies with higher
levels of social support and service user involvement in the development of the intervention. Studies of shorter duration also had
higher rates of adherence.
Conclusions: Adherence to mobile and Web-based interventions was robust across most studies. Although 2 studies found
specific predictors of nonadherence (male gender and younger age), most did not specifically analyze predictors. The duration
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of the study may be an important predictor of adherence. Future studies should consider reporting a universal measure of adherence
and aim to conduct complex analyses on predictors of adherence such as level of social presence and service user involvement.
(JMIR Mhealth Uhealth 2017;5(7):e94)   doi:10.2196/mhealth.7088
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patient compliance; schizophrenia spectrum and other psychotic disorders; mobile phone; mHealth
Introduction
E-mental health interventions, defined as “the use of information
and communication technology to support or improve mental
health care” [1,2], have been proposed as promising alternatives
to traditional interventions. Proposed benefits include ease of
use, accessibility, and the potential to be less stigmatizing [3-5].
This may be particularly appealing for service users with
psychosis who tend to have high relapse rates yet limited access
to psychological therapies [4,6]. Psychosis is a debilitating
mental health disorder that includes symptoms such as
hallucinations, delusions, disorganized thoughts, and speech,
as well as diminished emotional expression and lack of volition
[7]. Dropout and nonadherence rates for traditional
psychological and psychopharmacological interventions are
high for people with psychosis. “Dropout” is defined as
noncompletion of the study protocol or the study assessments,
and “adherence” is defined as the extent to which a participant
experiences or engages with a mobile or Internet-based
intervention [8]. Dropout rates of 25% for people with psychosis
[9-11] and 30-57% for people with first episode psychosis (FEP)
are commonly found [12]. Some have suggested that e-mental
health technologies may provide a more acceptable therapy
format than traditional face-to-face therapy [13]. Rates of
adherence across different types of e-mental health interventions
for people with psychosis have not been systematically
examined.
A recent review of 12 studies highlighted that a specific
examination of adherence, the extent to which a participant
engages with an intervention, would be helpful for the field of
e-mental health [14]. The study demonstrated that service users
with psychosis varied in their engagement with the technological
interventions; some showed regular or intermittent use and
approximately 25-30% of participants did not engage or dropped
out [14]. We seek to update this 2013 review for two main
reasons. First, since 2013, there has been a dramatic increase
in peer-reviewed publications examining Web-based or mobile
technologies for a variety of mental health conditions. When
reviewing the publication rate of e-mental health papers over
the past 20 years, 57% were published in the last 5 years and
the number of publications tripled between 2009-2014 [15].
Higgins and Green (2011) recommend that review updates
should be carried out every 2 years, especially in a rapidly
growing field [24]. Second, examining use and adherence to
these new technologies is increasingly important as the benefits
are limited if service users do not use them.
In order to obtain an overview of the rates of adherence, two
types of adherence rates were collected: (1) mean percentage
of the intervention completed and (2) percent of participants
that complete the intervention [16]. Previous systematic reviews
have developed four main approaches to examining adherence
to mobile or Web-based interventions for treatment of depression
and anxiety [8,16] (see Table 1 for an overview). The first is to
examine factors that contribute to dropout from a study; for
example, a comparison of baseline symptomology or
demographic factors in participants who stay in the study and
those who drop out. The second is to conduct statistical analyses,
including correlational or regression analyses within a study to
identify potential predictors of adherence. Specific service user
factors (eg, demographics and clinical severity) and intervention
factors (eg, week 1 vs week 2 of intervention) are most
commonly explored. The third is to use questionnaires to
retrospectively examine participants’ experiences of adherence
and perspectives on continued use. The fourth approach is to
experimentally manipulate factors within a study to impact upon
adherence; for example, to compare different technological
interfaces, frequency of use, or behavioral interventions.
Table 1. Four approaches to studying adherence.
Type of adherence data expectedApproach
Comparison of adherent and nonadherent service-user data including de-
mographic, symptom, cognitive or other data; baseline assessment of be-
tween group differences
Analysis of dropout data
Within study correlational, regression or other analysis of service-user
specific factors or intervention specific factors that may impact on the
level of adherence to intervention or technology
Within studies analyses to establish relationship between adherence and
various factors
Questionnaire data; qualitative or quantitative feedback on satisfaction,
acceptability of study or intervention with specific questions on usability,
helpfulness, and continued use
Poststudy questionnaire on participants’ experience
Comparison of interventions or interfaces that are specifically designed
to impact on adherence
Experimental manipulation of factors impacting adherence
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In addition to these four approaches to studying adherence, we
evaluated two theoretically proposed predictors of adherence:
(1) level of social presence or contact with a researcher, clinician
or peer, and (2) servicer user involvement in the development
of the intervention or app. The level of social presence or contact
refers to the frequency and quality of clinician, researcher, or
peer presence or contact throughout the intervention [14].
Several studies have identified that contact and support from
clinicians or peers in the form of telephone, email, Web-based
forums, or e-chats can help improve adherence to mobile and
Internet-based interventions; people with psychosis may
particularly benefit from this support [17,18]. Mohr et al [19]
outline a “supportive accountability model” whereby a
supportive social presence may positively influence
accountability, expectations, and bond during a mobile or
Web-based intervention. This predictor has some credibility as
Day et al [20] found that for acute inpatients with psychosis, a
positive relationship with a clinician was related to adherence
to medication and a positive attitude toward treatment. In
addition, LeClerc et al [11] established that a good therapeutic
alliance improved adherence to psychosocial treatment. This
review conducted a preliminary examination of the level of
social presence and support that is offered in each intervention.
The second potential predictor of adherence is the level of
service user involvement in the development of the intervention.
This has been highlighted as vital for effectiveness and
adherence to interventions [21]. The sense of involvement in
the project may promote self-efficacy and therefore
accountability to the intervention [19]. Recently, Wykes and
Brown [21] emphasized the importance of providing service
users with choice, for example, the choice of digital or
face-to-face interventions, or a combination of the modalities
[22]. Choice leads to a greater feeling of control; this may tap
into intrinsic motivation that is important for adherence to
interventions [19]. This review highlights any studies that
involve service users in the development and improvement of
the interventions and the potential impact on adherence. This
review updates Alvarez-Jimenz et al’s [14] findings; we
examined rates of adherence to mobile or Internet-based
interventions, trials, or observational studies for people with
psychosis.
Methods
This systematic review was conducted following the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) guidelines and recommendations for conducting and
reporting systematic reviews (see Multimedia Appendix 1) [23].
Eligibility Criteria
The following PICOS criteria [24] were adopted for study
inclusion: (1) population: adults (18-65 years); at least 75% of
participants have a diagnosis of schizophrenia spectrum disorder
according to diagnostic and statistical manual of mental
disorders (DSM)-IV or the international classification of diseases
(ICD)-10; (2) interventions, trials, or observational studies
involving Web-based, mobile, e-technology or Web-based
interfaces enabling peer-to-peer contact, patient-to-expert
communication, or interactive psycho education or therapy;
flexible, accessible monitoring, self-help, and symptom
management; (3) comparison group: none were specified; (4)
outcomes: at least one measure of adherence or dropout; and
(5) study design: as this study aimed to provide an overview of
the current state of the field, generous inclusion criteria were
adopted. Types of studies included all primary group studies
including RTCs; cross-sectional, longitudinal, and comparison
studies with and without a control group; cross-over trials, case
controls or cohort studies; observational studies with experience
sampling components (ESM); and feasibility or acceptability
studies. The following exclusion criteria were included: (1)
publications written in a language other than English, (2)
conference abstracts and theses not published in a peer-reviewed
journal, and (3) book chapters.
Information Sources and Search Strategy
The following databases were systematically searched from
August 2013 to November 2016: OVID including MedLine,
EMBASE and PsychInfo, Pubmed and Web of Science. The
following terms were used in the keyword search of abstracts
and titles: (Internet or online or Web-based or website or mobile)
AND (bipolar disorder or manic depression or manic depressive
illness or manic-depressive psychosis or psychosis or schizophr*
or psychotic). Additionally, hand-searching was performed on
5 key journals (Schizophrenia Bulletin, Schizophrenia Research,
Journal of Medical Internet Research, Telemedicine and
E-health, and Psychiatric Services) along with the reference
lists of included primary studies. The term “adherence” was
purposely not included in the search terms as most studies do
not include references to reported adherence in the title or
abstract [16].
JMIR Mhealth Uhealth 2017 | vol. 5 | iss. 7 | e94 | p.3http://mhealth.jmir.org/2017/7/e94/
(page number not for citation purposes)
Killikelly et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart.
Study Selection
Titles and abstracts of articles were scanned independently by
2 researchers (CK and ZH). Articles deemed potentially eligible
were retrieved in full and independently reviewed (CK and ZH).
Disagreement between researchers was dealt with by consensus
with a senior member of the research team (TW).
Data Collection Process
A standard form was used to extract data from selected studies
to create 7 results tables. Tables 2-7 comprise: (1) randomized
intervention studies, (2) feasibility or acceptability studies, and
(3) observational studies. Tables 2-4 include the following study
characteristics: study source, sample size, gender, age, diagnosis,
study design, purpose of intervention, and control group. Tables
5-7 include characteristics of interventions: levels of adherence,
dropout, type of social presence, service user involvement, and
measurement of participant feedback.
Assessment of Methodological Quality and Procedures
The study quality was assessed separately for RCTs, feasibility
studies, and observational studies (nonrandomized studies). The
RCTs and feasibility studies were separately assessed using the
clinical trials assessment measure (CTAM) [25]. The CTAM
was designed to assess trial quality specifically in trials of
psychological interventions for mental health. It contains 15
items grouped into six areas that are important for assessing
bias in psychological interventions that include sample size,
recruitment method, allocation to treatment, assessment of
outcome, control groups, and description of treatments and
analysis. Each study is rated out of a total of 100. This scale has
good interrater reliability (.96) and high concurrent validity
(.97) [26]. Observational studies were assessed using the Downs
and Black scale [27]. This scale comprises 27 questions
assessing key areas of methodological quality for
nonrandomized studies for systematic reviews. It includes
questions on reporting, external validity, bias, confounding, and
power. This scale was modified slightly for this study. The
question on power (see question 27 of the scale) was simplified
to a rating of 1 or 0 following the practice in other reviews
[2,28]. Each study is rated out of a total of 28 points. Scores are
classified in the following ranges: excellent 26-28, good 20-25,
fair 15-19, and poor less than 15. Two reviewers (CK and ZH)
independently assessed the quality for all of the included studies.
All of the first authors of the included articles were contacted
to approve their CTAM or Downs and Black rating and if
necessary provide further information to ensure that the quality
of the study was not confused with the quality of the reporting.
Results
Study Selection
The search strategy returned 2639 titles and abstracts. After
removal of 797 duplicates, 1842 titles and abstracts were
screened and 108 full text papers were assessed for inclusion.
In total, 20 studies met the inclusion criteria (see summary in
Figure 1; PRISMA flowchart).
Study Characteristics
Study characteristics are summarized in Tables 2-4. Six were
randomized controlled interventions; 7 were feasibility,
acceptability studies; and 7 were observational studies. In total,
656 participants with a diagnosis of schizophrenia spectrum
disorders and a mean age ranging from 20-48 years participated.
Sixteen studies included individuals with schizophrenia or
schizo-affective disorder, 1 study included people with first
episode psychosis, 1 included individuals with a dual diagnosis
of schizophrenia and substance misuse, and 2 included people
with nonaffective psychosis.
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Table 2. Study characteristics: randomized controlled trials with pre and post outcomes and control group.
Outcome measuresControl groupDescription of study
and type of technolo-
gy
Study de-
sign
Specific diagno-
sis (eg, FEPa,
chronic)
Age
Mean (SD)
n (%)
(male)
Study
source
(country)
First author
and year
Qualitative interviews
to assess perceptions
and experiences of de-
vices, PANSS, quantita-
tive feedback question-
naire
Cross-over con-
trol group
Use of mobile phone
or text messaging for
real time assessment
of symptoms
Random-
ized repeat-
ed measure
cross-over
design
Nonaffective psy-
chosis
33.04 (9.5)24 (19)United
Kingdom
Palmier-
Claus 2013
[29] (also
reported in
Ainsworth
et al, 2013)
[30]
Patient-rated COM-
RADEeCSQf
TAUdWeb-based informa-
tion and decision tool
to help patients identi-
fy needs and treatment
options
Random-
ized con-
trolled trial
Nonaffective psy-
chosis, DSMccri-
teria
Intervention:
37 (12.35),
control: 40
(13.47)
73 (39)Nether-
lands
Van der
Krieke
2013 [31]
Neurocognitive assess-
ment, WAISh, and oth-
ers, social skills perfor-
mance assessment, and
quality of life scale
TAU and social
skills training
combined with
computer skills
training instead
of COG REM
training
Social skills training
combined with Web-
based cognitive train-
ing (COG REM) to
improve memory and
attention
Random-
ized treat-
ment trial,
quasi exper-
imental de-
sign, blind-
ed raters
Schizophrenia or
schizoaffective
disorder
COG
REMggroup:
36.1 (12.8),
control: 37.1
(12.1)
56 (41)United
States
Kurtz 2015
[32]
Posttest video role
plays of interviews
scored by blinded
raters, self-report inter-
viewing confidence, 6-
month follow-up data
on employment out-
come
Waitlist con-
trols
Efficacy of virtual re-
ality job interview
training on job out-
comes and confidence
Random-
ized con-
trol study,
blinded
raters
Schizophrenia
and schizoaffec-
tive disorder
Intervention:
40.8 (12.2)
Control: 39.1
(10.6)
32 (17)United
States
Smith 2015
[33]
Symptoms: BPRSi,
medication adherence
scores
Cross-over
groups
Comparing the effect
of telephone calls on-
ly, text message only,
and telephone calls
and text messages on
symptoms and medica-
tion adherence
Small ran-
domized
control
study
Schizophrenia
spectrum disor-
ders
48.7 (11.6)30 (11)United
States
Beebe
2014 [34]
CES-Djdepression
scale, PHQ-9k, paranoia
checklist, PANSS
Waitlist con-
trols
Examined whether a
Web-based interven-
tion for depression
can ameliorate depres-
sive symptoms in
schizophrenia
Small ran-
domized
control
study
SchizophreniaIntervention:
38.9 (11.78),
Waitlist con-
trols: 43.41
(8.42)
58 (27)Germany
and United
Kindom
Moritz
2016 [35]
aFEP: first episode psychosis.
bPANSS: positive and negative syndrome scale.
cDSM: diagnostic and statistical manual of mental disorders.
dTAU: treatments as usual.
eCOMRADE: combined outcome measure for risk communication and treatment decision making effectiveness.
fCSQ: client satisfaction questionnaire.
gCOG REM: cognitive remediation.
hWAIS: Wechsler adult intelligence scale.
iBPRS: brief psychiatric rating scale.
jCES-D: Center for Epidemiologic Studies Depression.
kPHQ-9: patient health questionnaire- 9.
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Table 3. Study characteristics: feasibility studies.
Outcome measuresControl
group
Description of study and
type of technology
Study de-
sign
Specific diagno-
sis (eg, FEPa,
chronic)
Agen (%)
(male)
Study
source
(country)
First author
and year
Measures of attrition,
compliance, and social
Yes,
matched
Feasibility of use and effi-
cacy of a novel neuroplas-
Case-con-
trol study
Schizophrenia
spectrum disorder
Schizophre-
nia: 23.8
(3.2), con-
34 (25)United
States
Nahum
2014, [36]
cognition; facial memory,healthy
controls
ticity based Web-based
training program (So-
cialVille)
emotional prosody identi-
fication, emotion, and
social perception, Func-
trol: 23.6
(3.6)
tioning, QoLb, social and
role scales
SCIDc, BPRSd, CDSSe,
BAIf, Feasibility; usage
NoSafety of HORYZONS
Web-based psychosocial
Internet-based interven-
Single
group de-
sign
FEPMean 20.320 (10)AustraliaGleeson
2014 (up-
date of Al-
varez- of Web-based system,
User experience question-
naire, safety
tion, including peer-to-peer
networking, psychoeduca-
tion, Web-based psychoso-
cial intervention modules
Jimenez,
2013) [37]
Usability and satisfaction
questionnaire, working
alliance inventory
NoFeasibility study, clinical
social worker sent daily
text messages to assess
medication and clinical
status
Single
group de-
sign
Dual diagnosis
schizophrenia
and schizoaffec-
tive disorder and
substance misuse
Mean
40.47
17 (10)United
States
Ben-Zeev
2014 [3]
PANSSg, BDIh, BMQi,
acceptability or
usability measure, corre-
lation between symptoms
and use of phone
NoFeasibility of mobile app
resources to facilitate real
time illness self-manage-
ment; mood regulation,
medication management,
social functioning, sleep,
Single
group de-
sign
Schizophrenia or
schizoaffective
disorder
45.9 (8.78)33 (20)United
States
Ben-Zeev
2014, [38]
participants asked to com-
plete assessment then inter-
vention if required 3x daily
Calgary depression scale,
momentary assessment
scales, PANSS
noneFeasibility of a mobile
phone based momentary
assessment in individuals
with psychosis for clinical
3 groups of
patients
with differ-
ent levels
Acute
schizophrenia
and remitted,
UHR
Acute: 36.8
(10), remit-
ted: 35.5
(8), and
UHR: 22
(4.4)
44 (28)United
Kingdom
Palmier-
Claus 2013
(see Palmi-
er-Claus et
al, 2012 for
main
study), [39]
management and research
purposes
of psy-
chosis
MATRICS neuro-cogni-
tion, clinical global im-
NoneAcceptability of
PositScience’s Internet-
Pilot single
group de-
sign
Schizophrenia,
clinically stable
Not applica-
ble
9United
States
Ventura
2013 [5]
pression of cognition in
Schizophrenia, brief
based brain fitness pro-
gram using auditory dis-
crimination tasks questionnaire on knowl-
edge of cognition, out-
come rating scale
Feasibility measures, ad-
herence measures, satis-
faction questionnaires
NoneFeasibility and acceptabili-
ty of implementing
PRIMEj, a mobile app in-
tervention
Pilot single
group de-
sign
Schizophrenia
spectrum disor-
ders
Stage 1:
23.40 (2.6),
stage 2:
23.3 (3.7)
20 (17)United
States
Schlosser
2016 [40]
aFEP: first episode psychosis.
bQoL: quality of life.
cSCID: structured clinical interview for DSM disorders.
dBPRS: brief psychiatric rating scale.
eCDSS: Center for Doctoral Studies in social and behavioral sciences.
fBAI: Beck Anxiety Inventory
gPANSS: positive and negative syndrome scale.
hBDI: Beck depression inventory.
iBMQ: beliefs about medicines questionnaire.
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jPRIME: personalized real-time intervention for motivation enhancement.
Table 4. Study characteristics: observational and experience sampling method studies.
Outcome measuresControl
group
Description of study
and type of technology
Study designSpecific diagno-
sis (eg, FEPb,
chronic)
Age
Mean (SDa)
n (%)
(male)
Study
source
(country)
First author
and year
Comparison of baseline
scores and momentary
affective forecasting
throughout the week
NoHand-held device to
prompt in the moment
ratings of positive and
negative affect
Single group
design
Schizophrenia
or schizoaffec-
tive disorder
44.88 (9.27)
years
24 (17)United
States
Brenner
2014 [22]
Measures of emotional
granularity from
ESMcresponses and so-
cial functioning:
PSRSd, interview, abili-
ty task (MSCEITe)
Toronto Alexithymia
scale, or difficulty iden-
tifying feelings or test
of reading ability;
WTARf, BAIg, BDIh,
symptoms; SAPSi,
Neurcog; MATRICS
Yes, healthy
controls
Rating of momentary
emotions (sadness, anx-
iety, anger, and happi-
ness) using mobile
electronic devices
Case-control
study
Schizophrenia
spectrum disor-
der
Schizophre-
nia: 32.15
(9.19) years,
control:
23.95 (5.01)
104 (55)United
States
Kimhy
2014 [17]
Metacognitions around
worry; Negative beliefs
about ruminations
scale, meta-worry ques-
tionnaire,
NoneESM using a palm
computer to capture
whether worry and rumi-
nation are associated
with persecutory delu-
sions and hallucinations
Single group
design
Schizophrenia
spectrum disor-
ders, 3+ on the
PANSSjfor hal-
lucinations
33 (10.7)
years
32 ( 22)United
Kingdom
Hartley
2014 [41]
Self-report rating of
mood and symptoms
NoneThe use of mobile de-
vices to monitor symp-
toms in in-patient envi-
ronments
Single group
design
Schizophrenia
spectrum disor-
ders, in patient
setting
27.8 (6.3)
years
33 (18)United
States
Kimhy
2014 [9]
Symptoms: SAPS,
PANSS, PSYRATSk
NoneThe use of mobile de-
vices (PDA) to monitor
symptoms in inpatient
environments after the
introduction or reintro-
duction of antipsychotic
medication
Single group
design
In-patients with
acute delusions
scoring 4+ on
the PANSS,
schizophrenia
spectrum disor-
der
36.12 (range
20-63) years
26 (13)China and
the United
Kingdom
So 2013
[42]
PANSS, MATRICS
neurocognitive battery
Healthy con-
trol group
Ecological momentary
sampling to examine
the relationship be-
tween emotion, experi-
ence, and environment
Case-control
study
Schizophrenia
and Schizoaffec-
tive disorder
Schizophre-
nia: 39.55
(13.95), con-
trol: 36.83
(14.89)
88 (61)United
States
Sanchez
2014 [43]
Usability and acceptabil-
ity measures
NoneAcceptability of mobile
behavioral sensing
Pilot single
group design
Schizophrenia
spectrum disor-
ders
39 (12)20 (16)United
States
Ben-Zeev
2016 [6]
aSD: standard deviation.
bFEP: first episode psychosis.
cESM: experience sampling method.
dPSRS: positive symptom rating scale.
eMSCEIT: Mayer-Salovey-Caruso emotional intelligence test. 
fWTAR: Wechsler test of adult reading.
gBAI: Beck Anxiety Inventory
jBDi: Beck depression inventory.
iSAPS: scale for the assessment for positive symptoms.
jPANSS: positive and negative syndrome scale.
kPSYRATS: psychotic symptom rating scales.
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Table 5. Characteristics of interventions and rates of adherence: randomized controlled trials with pre and post outcomes and control group.
Measure of partic-
ipant feedback
and rating of ac-
ceptability
Service user in-
volvement in de-
velopment
Frequency of
social presence
Type of social
presence
Dropout rate
(%)
Adherence mea-
sure and rate
Length of studyFirst author
and year
Qualitative inter-
views with range
of perspectives
on usability, all
participants com-
pleted the feed-
back assessments
Participants were
interviewed about
their experience
Once or twice
per week based
on participants
preference
Once or twice per
week based on par-
ticipants prefer-
ence
1 asked to
have
SMSastopped
2 days early
due to rumi-
nation
(4.1%)
% of participants
completing the
intervention: 88,
(across all partici-
pants)
4x a day for 6 daysPalmier-
Claus 2013
(also report-
ed in
Ainsworth et
al, 2013)
[29,30]
30 used the Web
program
Open interviews
with 15 patients
to evaluate the in-
tervention
3 days a weekAssist was avail-
able to answer
questions over the
phone anytime
40(55%)% of participants
completing the
intervention: 71%
used full function-
ality of the web-
site
6 weeks, self-direct-
ed use of website
Van der
Krieke 2013
[31]
SST Mean num-
ber of ses-
sions=32.3
COG REM Mean
number of ses-
sions=31.9
Computer
skills=Mean
number of ses-
sions=32.2
Not applicableNot applicableInteraction with
clinician for both
COG REM and
computer Skills
training groups
SST group: 2x per
week for 50 min,
led by researchers
8(14.28%)% of participants
completing the
intervention:
100%, (min crite-
ria for inclusion;
all individuals re-
ceived at least
one session)
COG REMbtreat-
ment: 50 min/day 3
days/week for 23
weeks
SSTc: 50 min/day,
two days/week, for
23 weeks
Computer skills:
Target 50 hours over
23 weeks
Kurtz 2015
[32]
90% attendance
rates of sessions
None reportedDuring interven-
tion only briefly
Basic contact dur-
ing computer inter-
vention
2(6%)Mean % of en-
tries completed:
90% of sessions
attended and
completed
Up to 10 hours of
virtual interviews
over the course of 5
visits
Smith 2015
[33]
Phone calls plus
text message
group higher ad-
herence by a
mean of 5.3%
None reportedVariousVarious: weekly
telephone calls,
daily text mes-
sages, both
2(6.6%)Mean % of en-
tries completed:
81.60 (across all
participants)
3 monthsBeebe 2014
[34]
Feedback on use
of the program,
72% rated the
quality of the
program as good
to excellent
None reportedNoneNone- unguided9(15%)% of participants
completing the
intervention; 28%
used it once a
week
3 monthsMortiz 2016
[35]
aSMS: short message service.
bCOG REM: cognitive remediation.
cSST: social skills training.
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Table 6. Characteristics of interventions and rates of adherence: feasibility studies.
Measure of partici-
pant feedback and
rating of acceptabil-
ity
Service user in-
volvement in
development
Frequency of
social presence
Type of social pres-
ence
Dropout rate
(%)
Adherence mea-
sure and rate
Length of in-
tervention
First author
and year
Subjects took 8.1
weeks (mean) to
complete the 24 h
of training
Subjects rated
their satisfac-
tion in the train-
ing program
None reportedNone reported8(22-23% attri-
tion rate)
% of participants
completing the in-
tervention: 78
(completed 24 h of
the intervention
across all partici-
pants)
Total of 24 h
of Web-based
training, 1-2 h
per day for 6-
12 weeks
Nahum 2014
[36]
70% completed 30
weeks, 60% com-
pleted >3 Web-
based therapy
modules, and 75%
reported a positive
experience
Developed with
service user
group
Coaches moder-
ated Web-based
activity 2
hours/day
weekdays,
1h/day weekend
Peer-to-peer Web-
based social network-
ing
Coaches (expert
moderator)
None:
all accessed
modules
% of participants
completing the in-
tervention: 60
(completed at least
three modules, eg,
33%)
1 monthGleeson
2014 (update
of Alvarez-
Jimenez,
2013) [37]
Participants re-
sponded to 87%
(mean) of mes-
sages and 90% rat-
ed the intervention
easy to use, useful,
and fun
None describedDaily, up to 3
text messages a
day
Mobile intervention-
ist: clinical social
worker
5 (11%)Mean % of entries
completed: 87.00
(mean response
rate to text mes-
sages for all partic-
ipants)
12 weeksBen-Zeev
2014 [3]
90% rated the inter-
vention as highly
acceptable, 12%
reported it was a
complicated inter-
vention, reductions
in symptoms
PANSSaand BDIb
Developed
through service
user feedback
1x/weekResearcher called
participant to check
in and assist with
technical difficulties
1(3%)Mean % of entries
completed: 86.5
(rate of access to
the system for all
participants)
1 monthBen-Zeev
2014 [38]
82% of participants
met compliance
criteria of complet-
ing at least 33% of
the entries
None describedOnce or twice
per week based
on participants
preference
Researcher tele-
phoned participant
at least once per
week to offer advice
and encouragement
8(18%)Mean % of entries
completed:72 for
those who were
compliant with the
intervention (eg,
completed 33% of
data)
6x a day for 7
days
Palmier-
Claus 2013
[39]
5 participants com-
pleted 12 or more
sessions (75% of
patients reached
adherence criteria)
None reportedNot applicableRegular phone con-
tact with the study
team
1(11%)Mean % of entries
completed: 75 (re-
sponse rate across
all participants)
6 weeks, 2
hours/week
Ventura
2013 [5]
Mean overall satis-
faction with
PRIME 8/ 10
User-centered
design model
where partici-
pants gave feed-
back on the iter-
ative develop-
ment of
PRIMEcin two
stages
Once a day,
modified to the
service users
preference
Ranged from once a
week in stage 1, to
5x a week in stage 2
0Mean % of entries
completed (chal-
lenges completed)
At least once
per week for
12 weeks
Schlosser
2016 [40]
aPANSS: positive and negative syndrome scale.
bBDI: Beck depression inventory.
cPRIME: personalized real-time intervention for motivation enhancement.
JMIR Mhealth Uhealth 2017 | vol. 5 | iss. 7 | e94 | p.9http://mhealth.jmir.org/2017/7/e94/
(page number not for citation purposes)
Killikelly et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 7. Characteristics of interventions and rates of adherence: observational or experience sampling method studies.
Measure of partic-
ipant feedback
and rating of ac-
ceptability
Service user in-
volvement in de-
velopment
Frequency of so-
cial presence
Type of social
presence
Dropout rate
(%)
Adherence measure
and rate
Length of interven-
tion
First au-
thor and
year
Response rate
98.1%
None described2x/weekResearcher called
participant to
check in and assist
with technical diffi-
culties
NoneMean % of entries
completed: 98.10
(response rate across
all participants)
6x a day for 7 daysBrenner
2014 [22]
Not reportedNone describedNoneNone reported35(37%)Mean % of entries
completed: 79.15
(response rate across
all participants)
10x a day for 2
days
Kimhy
2014 [17]
Feedback ques-
tionnaire about
involvement
Once in a week,
but if needed addi-
tional phone con-
tacts were ar-
ranged
During the first
day, patients con-
tacted to ensure
functional equip-
ment
5 (15 %)Mean % of entries
completed: 59 (re-
sponse rate for com-
pleters; completion
of the schedule de-
fined as completing
at least half of the
entries (n=27))
10x a day for 6
days
Hartley
2014 [41]
81% response
rate
None reportedNone reportedIntroduction ses-
sion for 20 min on
first day
1(3%)Mean % of entries
completed: 81 (re-
sponse rate for all
participants)
10x a day for 1
days
Kimhy
2014 [9]
16 participants
met criteria for
minimum compli-
ance, completing
30 or more diary
entries
None reportedParticipants were
encouraged to
contact re-
searcher by
phone if prob-
lems
Contacted by re-
searcher at least 2x
during first week,
to offer support
and remind to
change battery
5 (19%)Mean % of entries
completed:70.7 (re-
sponse rate in partic-
ipants who complet-
ed at least 1/3 of en-
tries)
14 days 7x a day,
randomly
So 2013
[42]
Response rate to
calls was 80.6%
in patients and
81.3% in controls
None reported4x a day, each
patient was inter-
viewed about
their environ-
ment, goals, and
activities
Participants were
called 4x a day
4 (4%)Mean % of entries
completed: 80.16
(response rate for all
participants with
schizophrenia)
Phone call 4x a day
for 7 days
Sanchez
2014 [43]
95% felt comfort-
able using the
mobile phone
sensing system,
and 70% under-
stood how it
worked and did
not have difficul-
ty keeping the de-
vice with them
Post tudy usabili-
ty and acceptabil-
ity questionnaires
OnceOnce at the begin-
ning to set up
phone
0% of participants
completing the
study: 95% (one
participant did not
charge the phone
regularly)
Outpatients 2
weeks 12 hours a
day, inpatients 1
week 12 hours a
day
Ben-Zeev
2016 [6]
Quality Assessment
Trial quality assessment scores are summarized in Tables 8 and
9. The mean study quality score for the RCTs on the CTAM
was 77.3 (range 62-88). Five [31-35] of the RCT studies were
deemed to be of adequate trial quality (rating of 65+), except
for Palmier-Claus et al [29], which received ratings of 62. As
expected due to the lack of randomization, feasibility studies
(n=7) had a lower mean score (44.7). The mean quality rating
for the observational studies, was 20 and ranged from 17- 24.
Three studies fell into the “good” classification range and 4
were “fair.”
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Table 8. Clinical trials assessment measure (2004), assessment for randomized controlled trials, and feasibility studies.
Treatment de-
scription
(Q14,Q15)
(max 11)
Analysis
(Q12,Q13)
(max 15)
Control
(Q11)
(max 16)
Assessment
(Q6,Q7,Q8,Q9,Q10)
(max 32)
Allocation
(Q3,Q4,Q5)
(max 16)
Sample
(Q1,Q2)
(max 10)
Total
CTAMa(max
100)
Author and year
3,3,5= 115,6,4= 15010,6,0,0,0= 1602,0= 244Gleeson et al,
2014b[37]
3,0,0,= 35,6,4= 15010,6,0,0,0= 1602,0=236Ben-Zeev et al,
2014b[3]
3,3,0= 65,6,4= 15010,6,0,0,0= 1602,5=744Ben-Zeev et al,
2014b[38]
3,3,5=115,6,4=15010,6,0,0,0=1602,0= 244Nahum et al,
2014b[36]
3,3,0=65,6,4=15010,6,0,0,0,=1602,0=239Palmier-Claus
et al, 2013b[39]
3,0,3=65,6,4=151010,6,0,0,0=1610,3,0=132,0=262Palmier-Claus
et al, 2013 [29]
3,3,5=115,6,4=15610,6,10,0,0=2610,3,0=132,5=778Van der Krieke
et al, 2013 [31]
3,3,5=115,6,4=15010,6,0,0,0=1602,0=244Ventura et al,
2013b[5]
3,3,5=115,6,4=151010,6,10,3,3=3210,0,3=132,5=788Kurtz et al,
2015 [32]
3,3,5=115,6,4=15610,6,10,3,3=3210,3,0=132,0=279Smith et al,
2015 [33]
3,3,0=65,6,4=151010,6,10,3,0=2910,3,0=132,0=275Beebe et al,
2014 [34]
3,3,0=65,6,4=15610,6,10,3,0=2910,3,3=165,5=1082Mortiz et al,
2016 [35]
3,3,0=65,6,4=15610,3,10,0,0=2310,0,0=102,0=262Schlosser et al,
2016b[40]
aCTAM: clinical trials assessment measure.
bThe study is designed as a feasibility or acceptability trial. For ratings of treatment description: Q14 score 3 if website or mobile interface adequately
described; for ratings of handling of dropouts, if dropouts described and reasonably analyzed score of 4 given.
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Table 9. Trial quality characteristics for nonrandomized controlled trials: Downs and Black (1998) ratings.
Ben-
Zeev
2016 [6]
Sanchez 2014
[43]
So 2013 [42]Hartely 2014 [41]Kimhy 2014 [9]Kimhy 2014 [17]Brenner and Ben-
Zeev 2014 [22]
Checklist Ques-
tion
1111111Question 1
1111111Question 2
1111111Question 3
1111111Question 4
1122222Question 5
1111111Question 6
1111111Question 7
1011111Question 8
1010101Question 9
1111110Question 10
1110UTDUTDa0Question 11
10111UTD0Question 12
1111111Question 13
0000000Question 14
UTDUTD0UTDUTDUTD0Question 15
1111111Question 16
UTD111111Question 17
1111111Question 18
UTD111111Question 19
1111111Question 20
1111111Question 21
UTDUTD11111Question 22
0000000Question 23
0000000Question 24
UTD111110Question 25
1011UTDUTD1Question 26
0011UTD00Question 27
18172422211919Total
aUTD: unable to determine.
Adherence: Types of Measurement Across Studies
The most common measures of adherence were percent of
intervention completed by participants and percentage of
participants completing the intervention. Figure 2 displays the
types of adherence measure used and the level of adherence for
each study. For the 12 studies reporting mean % of the
intervention completed by participants, adherence ranged from
70.7-98.0% with a mean of 83.4%. For the 8 studies reporting
the percentage of participants completing the intervention,
adherence ranged from 28- 100% with a mean of 74.3%. All of
the studies also listed the number of participants that dropped
out of the study. This ranged from 0-55% with a mean of 12.3%
dropout across both observational and intervention studies.
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Figure 2. Adherence across all studies: mean percent of entries completed in each study followed by percentage of participants completing the
intervention.
Approach 1: Analysis of Dropout
See Tables 5-7 for details of rates of dropout. Five studies
analyzed the relationship between specific variables and dropout.
In terms of the variables of age or gender and dropout, most of
the studies found no relationship [29,41,42]; however, Van der
Krieke et al [31] found that the dropouts tended to be younger
and male. Hartley et al [41] and So et al [42] did not find a
relationship between symptom severity and dropout; however,
Palmier-Claus et al [29] (also reported in the original study [30])
found that higher severity on the positive and negative syndrome
scale’ (PANSS) positive symptom subscale predicted dropout.
Finally, Sanchez et al., [43] found that the level of cognitive
functioning did not predict completion of the study. See Table
10 for a summary.
Table 10. Summary of findings for predictors of dropout and adherence.
GenderAgeSeverity of symptomsCognitive functioningChronicity or duration of symptomsStudy
YesYesYesaVan der Krieke et al, (2013)
[31]
NoNobBen Zeev et al, (2014) [38]
NoNoYesNoPalmier-Claus et al, (2013)
[39]
NoNoNoNoSchlosser et al, 2016 [40]
NoKimhy et al, (2014) [17]
NoNoNoHartley et al, (2014) [41]
NoNoNoSo et al, (2013) [42]
NoSanchez et al, (2014) [43]
Time to complete an entryDuration of the study
NoYesPalmier-Claus et al, (2013b)
[29]
a“Yes” indicates that the variable was found to significantly predict nonadherence or drop out.
b“No” indicates that no relationship was found.
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Approach 2: Analysis of Within Study Predictors of
Adherence
Six studies conducted within-study analyses to examine
adherence predictors and found few significant predictors of
adherence. Van der Krieke et al [31] analyzed the chronicity of
symptoms and reported that service users with first episode
psychosis used a Web-based decision aid autonomously more
often than service users with chronic psychosis. For those who
required assistance from the research team to complete the
intervention, 56% were service users in long-term care.
However, the report does not provide specific statistical data.
In terms of intervention specific factors, Palmier-Claus et al
[29,30] found no relationship between the length of time taken
to complete an entry and the number of entries completed by
an individual. They also examined number of entries completed
across the number of weeks of the study. They found that more
entries were completed in the first week than the second week
of the intervention and participants rated more highly the
question, “were there times when you felt like not answering?”
during the second week.
Approach 3: Poststudy Questionnaires on Participants’
Perspectives on Adherence
11 studies retrospectively asked participants to provide
questionnaire-based qualitative or quantitative feedback about
their experience of the study or intervention. All the studies
used different rating scales (eg, Treatment Experience
Questionnaire in Smith et al [33], idiosyncratic quantitative
feedback questionnaire in Palmier-Claus et al [29], and
idiosyncratic SocialVille program rating in Nahum et al [36])
and therefore it is difficult to draw comparisons across studies.
Four studies specifically asked whether participants would
continue to use the intervention [33,35-37]; see Figure 3). For
4 studies, the mean percent of participants who agreed to
continue to use the intervention was 73.1%.
Figure 3. Percent of participants agreed to continued use of intervention.
Approach 4: Analysis of Specific Intervention
Manipulations and Effect on Adherence
Two studies were designed to manipulate conditions that may
have an impact on adherence. Palmier-Claus et al [29,30]
compared two different types of interventions: SMS text-only
(short message service, SMS) interface or a mobile phone–based
graphical app. They assessed the acceptability and feasibility
of each device and found that participants completed more data
points when using the mobile phone interface (mean
entries=16.5) compared with the SMS text-only interface (mean
entries=13.5; P=.002). Schlosser et al [40] increased the
frequency and intensity of contact from a research coach from
once a week to 5 times a week. This led to improved rates of
adherence, for example, number of logins increased from 3.51
days/week to 4.69 days/week.
Interestingly two interventions found that adherence significantly
affected the intervention efficacy. Smith et al [33] found that
completing more training trials of a virtual reality job interview
training correlated with fewer weeks searching before securing
a job (P<.001) and greater self-confidence (P=.03).
Ben-Zeev et al [38] analyzed symptom change throughout the
intervention and any related association to adherence and found
that change in participants’ Beck Depression Inventory (BDI)
scores were significantly correlated with use of mobile
intervention; less frequent use of the FOCUS mobile intervention
was associated with a the greater the reduction in depression
score. Change in PANSS scores was not associated with use of
the FOCUS app.
New Potential Predictors of Adherence
Potential Predictor: Social Presence Analysis
To assess Mohr et al’s [19] “supportive accountability” model
(social presence leads to better adherence), we examined the
amount of contact for each study and the level of adherence to
the intervention. As there is heterogeneity across the studies,
we provide a narrative synthesis. Across all 20 studies the mean
number of contacts per week from a researcher or clinician was
4.4 and it ranged from 0-28 contacts per week. This included
face-to-face, mobile, Web-based or telephone-based contacts.
As presented in Figure 4, regardless of level of support there is
still a moderate to high rate of adherence across all 20 studies.
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Interestingly, it appears that studies with very high contact have
almost 10% higher rates of adherence (83.8%) than those with
no support (71.1%), but studies with minimal contact also had
high adherence ratings (82.5%). Anecdotally, the importance
of social presence is confirmed from participant reports. Gleeson
et al [37] found that 90% of participants cited the use of a
Web-based facilitator contributed to their sense of safety when
using the Web-based program. All participants either agreed or
strongly agreed with statements such as they always felt
supported by the Web-based facilitator and 60% reported an
increase in feelings of social connectedness. Recently, Schlosser
et al [40] found that increasing the frequency of contact with a
research coach increased use of the mobile app PRIME
significantly. They found that when service users were able to
tailor the amount of social support they received, they engaged
more with the app.
Figure 4. Relationship between social presence and adherence, adherence rates are grouped by frequency of social contact per week from “very high”
(20 or more contacts per week), “high” (5 to 10 contacts per week), “minimal” (1 to 3 contacts per week), or “no support” (no contact).
Potential Predictor: Service User Involvement
Of the 20 studies included, only 3 described service user
involvement in terms of the development or initial piloting of
the intervention.
Coproduction, meaning the collaboration of service users and
researchers, in the beginning phases of intervention development
has a potential influence on participants’ perception and
adherence to the intervention. Ben-Zeev et al [38] used feedback
and recommendations from a pilot with service users to develop
a mobile intervention, FOCUS, to facilitate real-time mobile
illness self-management. They found that participants rated the
intervention highly with 90% acceptability and the mean percent
of entries completed was 86.5%. Gleeson et al’s [37]
HORYZONs program was developed with a service user focus
group. It was found that 95% of participants used the social
media component, 60% completed the therapy modules, and
75% reported a positive experience with the program. Schlosser
et al [40] used an iterative service user feedback process called
user centered design (UCD) process. After using the mobile
app for 1 week, service users were consulted by means of
in-depth interviews about their experience and identified key
areas for improvement. The recommended changes were
incorporated into the design of the device and this led to a 2 to
3-fold increase in use of the app in week 2. Service users also
rated the app at 8 out of 10 in terms of satisfaction. In this case,
service users were directly involved in the design, development,
and implementation of the new device. When compared with
adherence ratings (mean rate of adherence across studies that
used different types of adherence ratings) to feasibility studies
or RCTs that did not involve service users (mean adherence rate
of 78%), service user involvement was associated with higher
adherence (mean of 89%), though this is a small number of
studies (n=3).
Additional Potential Predictor: Duration of Study
Interestingly, a comparison of the duration of the study (number
of days participants are expected to be active in the study) and
levels of adherence (averaged across both types of adherence
ratings) revealed that the studies with the shortest duration had
the highest mean rates of adherence (see Figure 5). The duration
of the ESM-based studies ranged from 1 day to 14 days and the
mean rate of adherence for these studies was 82.7%. Conversely,
the duration of the RCT studies ranged from 6-161 days with a
mean adherence rating of 76.4%; the duration of feasibility
studies ranged from 7 -84 days with a mean adherence rating
of 79.7%.
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Figure 5. Adherence ratings and the mean duration of the study (number of days) grouped by study type.
Discussion
Principal Findings
This is the first review to document rates of adherence and to
explore predictors of adherence to mobile and Web-based
interventions for people with psychosis. Overall, from the
examination of the four approaches to studying adherence across
these diverse studies, we conclude that adherence to mobile and
Web-based interventions is not necessarily predicted by service
user specific factors such as age, symptoms, or gender. However,
people with FEP may prefer an intervention that they can
independently access [31]. Additionally, adherence is moderate
to high across specific intervention factors such as amount of
time to complete an entry and across different study designs.
However, service users may prefer the mobile phone interface
and may adhere more in the first week of an intervention [29].
This review has important implications for the acceptability and
use of current interventions and the development of new ones.
For example, offering service users choice in terms of the
duration of the intervention and also the mode of delivery may
have an important influence on adherence. Some service users
may prefer a mobile app whereas others prefer a Web-based
platform. Two potential new predictors of adherence were
explored: (1) more frequent social support and (2) service user
involvement in the intervention development. Providing service
users with more input and control may add to the value and use
of these interventions.
The Measurement of Adherence
Overall, adherence rates (whether measuring mean percentage
of the intervention completed or percent of participants that
complete the intervention) to mobile and Web-based
interventions for people with psychosis are in line with
adherence rates for similar technology-based interventions for
other mental health disorders. Rates of adherence to
interventions for depression and anxiety are approximately 66%
for self-care interventions [16], and a median 56% for a
computerized cognitive behavioral therapy (CBT) intervention
[44]. Rates for completion of a Web-based site for personality
disorder ranged from 80-100% completion; social phobia
reported 70-90% completion and the only post-traumatic stress
disorder (PTSD) intervention reported completing rate of 64%.
In terms of adherence across different types of interventions
(eg, face-to-face; medication-based interventions), completion
rates of a one-to-one CBT intervention for psychosis was 55%
[45] and 68.3% for a one-to-one CBT intervention for FEP [46].
Overall, the current review found moderate to high levels of
adherence to Web-based or mobile interventions for psychosis
with a range of 60-100% and a mean of 83%.
In terms of the four approaches to studying adherence, the
studies in this review varied in terms of the within-study
predictors that are associated with adherence, questionnaires
used to assess participants’ perspectives on factors impacting
adherence, and whether or not they conducted any experimental
manipulations to impact on adherence.
Predictors of Adherence and Dropout
Only 2 studies found specific predictors of adherence: less
chronic symptoms [31] and a higher rate of adherence was found
in the first intervention week than the second [29,30]. Although
other predictors of adherence were examined (age, gender,
cognition, negative symptoms, and persecutory delusions), none
were found to have a significant effect. Two studies also found
significant predictors of dropout: severity of symptoms [39],
younger age, and male gender [31].
Complex analyses, such as the multiple regression analysis
performed by Palmier-Claus et al [39] of specific predictors
such as service-user factors (symptoms, socioeconomic factors,
interpersonal factors, and cognitive factors) along with e-mental
health intervention factors (complexity of the interface, cost,
and access) should be a priority for future studies. This will
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inform which service-user group may adhere to different type
of interventions.
One interesting area of future research would be to examine the
duration, frequency, and intensity of the intervention and the
effect that this may have on adherence. Studies that last for
several months may have more variable adherence than those
that last only 1 week. Additionally, longer adherence is not
always synonymous with better outcomes. Palmier-Claus et al
[29] found that the longer participants used the app, the greater
the increase in their depression symptoms. This has important
implications for future research; it could be that people will stop
using the app as they improve and should therefore be given
the opportunity to stop using the app when they have exceeded
the benefit. Ultimately, it may be most effective to allow service
users choice of the duration, frequency, or intensity of
interventions. With supportive guidance, service users may best
be able to decide whether or not a technology is helpful and
supportive in their recovery.
Poststudy Questionnaires
Several studies used participant feedback questionnaires,
however, they were all different; some were previously
published but most were idiosyncratic and this variability also
hindered comparison. A standard questionnaire specifically for
Web-based and mobile interventions could provide detailed and
comparable information on the service user perspective and
experience. Additionally, more independent data collection,
perhaps from service user researchers not associated with the
study, may provide a more unbiased and critical view of the
interventions (eg, [47]). The use of posttrial feedback should
be a priority for future research studies.
Experimental Manipulation
Only 2 studies specifically manipulated variables in an attempt
to influence adherence or use of the intervention. Both
successfully improved adherence to the intervention (eg, mobile
phone rather than text message based delivery; higher frequency
supportive contact). Experimental manipulation of variables is
vital particularly in terms of the types of technologies service
users would prefer, the content of interventions and the level
of independence, or clinician involvement in use of the
intervention.
New Predictors of Adherence
“Support” in this review was defined liberally as any type of
contact with a clinician or researcher involved in the study. Of
the 20 studies, 14 reported some level of clinician or researcher
contact. This ranged from very limited initial interaction with
a researcher to multiple daily support calls from a dedicated
mobile interventionist. It should be noted that 7 of the studies
were designed as observation studies with ESM components.
In this case, researcher or clinician contact may only occur if
service users stop filling in the data. Additionally, ESM studies
are usually very short so there is less time for absolute dropout.
As evidenced by our comparison with adherence ratings grouped
by the duration of the study, ESM studies tended to be the
shortest studies with the highest adherence ratings.
At present, it is difficult to draw clear conclusions about the
importance of support, as only 2 studies specifically reported
data on the effect of the Web-based interventionists [37].
However, as demonstrated by Schlosser et al [40], when the
amount of coaching support was increased during the second
half of the intervention, it led to increased engagement. In the
future, it would be interesting for studies to experimentally
manipulate the level of support and then measure the impact on
adherence, or correlate the ratings of therapeutic alliance in the
intervention and the level of adherence. This will clarify the
impact of social presence.
Alvarez-Jimenez et al [14] and Wykes and Brown [21]
recommend that service user involvement in intervention
development might be an important predictor of adherence.
However, in the current dataset, only 3 studies included service
users in the development of the intervention, so it is difficult to
draw conclusions about the impact on adherence. However,
adherence to these interventions was very high (84.9%, 86.5%,
and 95%). This is an important area requiring future study.
Quality of Studies
As expected, the RCT studies were rated more highly (77.3%)
than feasibility studies (44.7%). All of the studies had
interventions carried out by independent assessors and had
adequate handling and assessment of dropouts. Only 4 studies
had outcome assessments conducted by assessors blind to group
allocation. In terms of observational studies, these studies were
classified as either fair or good in terms of the quality. Few
studies (n=4) used a method of blind rating of outcomes. This
is particularly important when assessing service user satisfaction
with the intervention, as researcher involvement may
unintentionally bias the ratings. Finally, it is difficult to compare
study quality across feasibility, RCT, and observational studies.
Currently there is no measure to assess the quality of feasibility
studies. The CTAM and Downs and Black scales provide a
useful reference point; however, direct comparisons are not
possible. In the future, RCTs should be developed from the
feasibility studies discussed here, to provide further, high quality
support for these initial findings.
Strengths and Limitations of the Review and
Recommendations
One of the main limitations of this study is the difficulty of
comparing rates of adherence across studies with different
interventions and different outcomes. Although most studies
provided data either as percent of individuals completing an
intervention or the mean percentage of an intervention
completed, these two measures may not provide as accurate
information when directly combined. A universal measure of
adherence should be adopted in addition to more detailed
information on the quantity or quality of adherence. For
example, Simco et al [16] recommended including not just the
percentage of an intervention completed but the number of
exercises per week or log-ins per week to get a more qualitative
perspective on use. Along these lines, it will be important for
future reviews to separate and compare the modes of delivery
in their analysis of baseline adherence levels. For example, the
baseline rate of adherence to a mobile phone intervention may
be different than for a Web-based intervention; comparisons
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across and within modes of delivery may provide insight into
the types of technologies that are preferred. Finally, it will be
important for future reviews to carefully document and unpick
any potential risks of harm that service users may experience
when using these remote technologies. Reviews should provide
an unbiased account of both the benefits and disadvantages of
remote interventions, for example, as highlighted by the finding
by Ben-Zeev et al (2014b) that participants’ BDI scores were
significantly correlated with use of mobile intervention; less
frequent use of the FOCUS mobile intervention was associated
with a greater reduction in depression score. This is an important
finding that should guide further use of this intervention (eg,
Ben-Zeev et al, 2016). Any potential negative effects should be
carefully explored and documented.
The review provides a comprehensive, up-to-date review of
adherence across a variety of intervention types and platforms.
The strengths include assessing a broad range of different novel
technological interventions from text message-based to
Web-based to virtual reality-based programs. This allowed us
to demonstrate that adherence across different types of studies
and a diverse range of interventions is moderate to high.
Although the choice between face-to-face and remote
intervention was not examined, this result at least demonstrates
potential clinical utility. This review is timely as we included
up-to-date literature from the past 3 years to ensure that the
reader is informed of the most recent developments. The review
also provides an innovative exploration of theoretically proposed
predictors of adherence. This is the first review of its kind to
explore the importance of service user involvement and support
in facilitating adherence.
We conclude that specific service user factors such as age or
symptom severity may not have a significant influence on
adherence; however, the experience of the service user in terms
of the development of these technologies and interventions may
be an important factor that requires care and consideration.
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